China Pharma Holdings (CPHI) Net Equity Issued and Repurchased (2021)

China Pharma Holdings (CPHI) posted Net Equity Issued and Repurchased of $7.3 million for Q4 2021, up 438.26% on a QoQ basis from -$2.2 million in Q3 2021.

China Pharma Holdings (CPHI) Net Equity Issued and Repurchased (2021) Analysis & Trends

China Pharma Holdings' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $7.3 million for Q4 2021.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $7.3 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $5.0 million (changed N/A YoY) and the FY2021 annual result came in at $5.0 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was $7.3 million for Q4 2021 at China Pharma Holdings, up from -$2.2 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $7.3 million in Q4 2021 and bottomed at -$2.2 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 China Pharma Holdings 629,344.02 460,870.02 285,487.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 7.32 Mn
Dec 31, 2021 7.32 Mn
Sep 30, 2021 -2.16 Mn
Sep 30, 2021 -2.16 Mn
Jun 30, 2021 -301.00
Jun 30, 2021 -301.00
Mar 31, 2021 -154,215.00
Mar 31, 2021 -154,215.00